Fertility Preservation in Patients with Endometrioma

Jennifer Hirshfeld‐Cytron, Candace Tingen, Teresa K. Woodruff
In: Endometriosis · 2011 · pp. 555–559 · doi:10.1002/9781444398519.ch55 · W1548159109
other OA: closed CC0
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper reviews current research on endometriosis diagnostics and medical therapies, including progesterone and estrogen receptor modulators and antiangiogenic agents, highlighting that surgical excision remains the gold standard.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The ultimate goals of endometriosis research are better diagnostics, especially for early stage and mild disease, and effective medical therapies that cure the disease. New candidate targets for diagnostics and therapeutics are most likely to be identified from fundamental research into the pathophysiology of endometriosis. Progress in these endeavors will depend on funding and the ability of researchers to maximize resources through collaboration and multidisciplinary approaches. Medical treatments undergoing investigation include progesterone and estrogen receptor modulators, statins, aromatase inhibitors, antiangiogenic agents, and immune modulators such as anti-tumor necrosis factor-α. None of these medical treatments is yet able to supplant surgical excision of endometriotic lesions as the gold standard for treatment. Despite the impediments to endometriosis research that include variable symptoms, multiple genetic and environmental causative influences and a lack of good experimental models, significant progress is being made in improving understanding of basic disease mechanisms, and in new approaches to diagnosis and treatment.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (58)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-01T06:31:07.846910+00:00
License: CC0 · commercial use OK